| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $661.8M | +8.9% |
| Cost of Revenue | $77.9M | -7.0% |
| R&D Expense | $108.8M | +18.8% |
| SG&A Expense | $321.6M | -4.4% |
| Operating Income | $81.7M | +1649.9% |
| Interest Expense | $0 | -100.0% |
| Pre-tax Income | $97.9M | +3434.5% |
| Income Tax | $24.0M | +1552.1% |
| Net Income | $73.9M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $69.3M | -7.6% |
| Accounts Receivable | $142.1M | -1.4% |
| Inventory | $54.3M | -29.9% |
| Current Assets | $686.1M | +39.1% |
| Total Assets | $1.37B | +7.1% |
| Current Liabilities | $292.4M | +0.8% |
| Total Liabilities | $332.3M | -6.7% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $172.0M | +54.8% |
| Capital Expenditures | $725K | +31.6% |
| Investing Cash Flow | -$189.9M | -170.7% |
| Financing Cash Flow | $12.2M | +103.1% |
| Free Cash Flow | $171.2M | +54.9% |
| +5512.8% |
| EPS (Basic) | $1.34 | +6600.0% |
| EPS (Diluted) | $1.32 | +6500.0% |
| Stockholders' Equity |
| $1.04B |
| +12.4% |